3rd Quarter - Report

BOCKORNY GROUP, INC. for GENERIC PHARMACEUTICAL ASSOCIATION

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Copyright/Patent/Trademark CPT

Issues relating to Patent Settlements.

LobbyistCovered position, as disclosed
NICOLE VENABLE —

Contacted: HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); SENATE; Health & Human Services, Dept of (HHS)

Health Issues HCR

Drug Affordability and Access Issues Issues related to Risk Evaluation and Mitigation Strategies

LobbyistCovered position, as disclosed
DAVID BOCKORNY —
MARTINA L. BRADFORD —
BLAIR C LARKINS —
NICOLE VENABLE —

Contacted: Health & Human Services, Dept of (HHS); SENATE; HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA)

Medicare/Medicaid MMM

Issues Relating to Medicare Part D

LobbyistCovered position, as disclosed
DAVID BOCKORNY —
MARTINA L. BRADFORD —
BLAIR C LARKINS —
NICOLE VENABLE —

Contacted: Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE

Budget/Appropriations BUD

Ag-appropriations language related to labeling issues

LobbyistCovered position, as disclosed
BLAIR C LARKINS —
NICOLE VENABLE —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA)

Pharmacy PHA

Issues Related to Biosimilar Regulation, Labeling, E-Labeling and Access

LobbyistCovered position, as disclosed
DAVID BOCKORNY —
MARTINA L. BRADFORD —
BLAIR C LARKINS —
NICOLE VENABLE —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.